An exploratory, randomised, controlled, parallel-group, open-label study to evaluate different dosing regimens of rabeprazole in controlling nocturnal heartburn (NT HB) symptoms in uninvestigated symptomatic gastroesophageal reflux disease (s-GERD)
Conferences